Products & Medication Guides
Committed to Transparency and Patient Safety
At Oxford Pharmaceuticals, we believe that access to clear and accurate medication information is part of delivering quality healthcare.
Certain products we manufacture include a corresponding FDA-approved Medication Guide, available digitally for download and printing. These guides provide essential information on dosage, use, and safety for patients and providers.
Oxford’s medication guides are regularly updated to reflect the most current FDA labeling and approval information. Whenever revisions are made, the digital version on this page will be replaced with the latest approved version.
Request Printed Medication Guides
To request pre-printed Medication Guides or Patient Information Sheets be sent to your location, please contact our Customer Service Department:
Oxford Products and Medication Guides
| Product Name | Medication Guide (PDF) | Links |
|---|---|---|
| Amlodipine Besylate Tablets | View PDF | Prescribing Information |
| Buspirone HCl Tablets | View PDF | Prescribing Information |
| Carisoprodol Tablets | Not Applicable | Prescribing Information |
| Glipizide Tablets | Not Applicable | Prescribing Information |
| Hydrochlorothiazide Tablets | Not Applicable | Prescribing Information |
| Imipramine HCl Tablets | View PDF | Prescribing Information |
| Methocarbamol Tablets | Not Applicable | Prescribing Information |
| Primidone Tablets | View PDF | Prescribing Information |
| Sotalol HCl Tablets | Not Applicable | Prescribing Information |
| Spironolactone Tablets | Not Applicable | Prescribing Information |
| Trazodone HCl Tablets | View PDF | Prescribing Information |
Regulatory Commitment
Oxford Pharmaceuticals complies with all FDA Medication Guide distribution requirements and Good Manufacturing Practices (cGMP).
Our labeling and patient information procedures are continuously audited for accuracy and timeliness to ensure that healthcare professionals and patients receive the most reliable information available.
Quality & Compliance
Built to the Highest Standards of Pharmaceutical Manufacturing
Oxford Pharmaceuticals operates under current Good Manufacturing Practices (cGMP) as described in the Code of Federal Regulations (CFR) Title 21 Parts 210 and 211.
Our facility includes advanced Quality Control and Analytical Laboratories, walk-in stability chambers, and controlled access DEA vaults for Schedule II–V products. Each batch we produce undergoes rigorous testing to ensure it meets or exceeds all U.S. Pharmacopeia (USP) standards before release.
We maintain a zero-tolerance approach to deviation and maintain continuous improvement protocols across all operations. Transparency, traceability, and accountability are at the core of how we protect patients and partners alike.
Third-Party Testing and Regulatory Oversight
Oxford engages accredited third-party laboratories for independent verification of purity, potency, and stability. This ensures our products not only meet FDA standards but also uphold our own higher internal benchmarks.
Regular internal audits and third-party inspections reinforce our commitment to compliance excellence. Every manufacturing, blending, and packaging process is documented and validated for full regulatory traceability.